Home > Insider Trading > Filing (0001209191-20-023395)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1667633	Forty Seven Inc.	FTSV	Pharmaceutical Preparations (2834)	474065674

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1743780	H Chris Takimoto	C/O Forty Seven, Inc. 1490 O'Brien Drive, Suite A Menlo Park CA 94025	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-04-01	49,627	$2.02	53,533	No	4	M	Direct
Common Stock	Acquisiton	2020-04-01	8,333	$4.88	61,866	No	4	M	Direct
Common Stock	Acquisiton	2020-04-01	7,020	$5.27	68,886	No	4	M	Direct
Common Stock	Acquisiton	2020-04-01	11,418	$8.76	80,304	No	4	M	Direct
Common Stock	Acquisiton	2020-04-01	2,797	$35.75	83,101	No	4	M	Direct
Common Stock	Disposition	2020-04-01	79,195	$95.42	3,906	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-04-01	49,627	$0.00	49,627	$2.02
Common Stock	Stock Option (right to buy)	Disposition	2020-04-01	8,333	$0.00	8,333	$4.88
Common Stock	Stock Option (right to buy)	Disposition	2020-04-01	7,020	$0.00	7,020	$5.27
Common Stock	Stock Option (right to buy)	Disposition	2020-04-01	11,418	$0.00	11,418	$8.76
Common Stock	Stock Option (right to buy)	Disposition	2020-04-01	2,797	$0.00	2,797	$35.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
58,114	2020-02-08	2026-02-25	No	4	M	Direct
4,570		2027-08-14	No	4	M	Direct
70,398		2027-11-27	No	4	M	Direct
44,710		2028-04-26	No	4	M	Direct
113,153		2029-12-12	No	4	M	Direct

Footnotes

Includes 3,906 shares acquired under the Forty Seven, Inc. 2018 Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.411 to $95.43, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares subject to the option vest in a series of 48 successive equal monthly installments commencing on August 15, 2017, subject to Reporting Person's continuous service as of each such date.
The shares subject to the option vest in a series of 48 successive equal monthly installments commencing on November 8, 2017, subject to Reporting Person's continuous service as of each such date.
The shares subject to the option vest in a series of 48 successive equal monthly installments commencing on March 1, 2019, subject to Reporting Person's continuous service as of each such date.
The shares subject to the option vest in a series of 48 successive equal monthly installments commencing on December 13, 2019, subject to Reporting Person's continuous service as of each such date.